Radboudumc is the first university medical center to receive the Ben Willem Mol Award, recognizing its strong performance in appropriate care evaluation studies (ZE&GG), rapid local study start-up, and pragmatic collaboration across research teams and support services.
Radboudumc received the Ben Willem Mol Award in November for its contribution to appropriate care evaluation studies in the Netherlands. The award recognizes research teams and healthcare organizations that are particularly successful in translating clinical research into practice, with strong patient participation and efficient study implementation.
This year, the award specifically considered how quickly participating centers are able to start recruiting patients after approval by the Medical Research Ethics Committee. Radboudumc stood out with an average local start-up time of only 41 days.
The medical center also performs strongly in patient inclusion and acts as coordinating center for several national appropriate care evaluation studies, including DISTANCE, DREAM-TWO, GENPAD, and LIMONCELLO.
A team effort
Marjan de Vries from the Department of Surgery will receive the award on behalf of Radboudumc, together with research coordinator Linda Garms and Wendy van Eldijk from the Local Feasibility Service Desk at the Research Institute.
According to De Vries, the recognition reflects the work of many people involved in setting up and running clinical studies.
“Starting and conducting these research projects is truly a team effort,” she says. “Patients, researchers, research professionals, and supporting departments all play an essential role. If a study gets stuck at one point in the process, the entire project is delayed.”
Research professionals often form the link between these different parties. Within the Department of Surgery, Garms helps coordinate study start-up and implementation, while also sharing her experience with PhD candidates and making use of her network across Radboudumc.
De Vries also highlights the importance of the local feasibility process. “It makes a real difference that we can rely on an efficient and proactive process. Applications are picked up quickly and, if something is unclear, colleagues often simply call the applicant instead of letting questions go back and forth. That helps us get documentation and approvals in place in a relatively short time.”
From left to right: Marjan de Vries, Linda Garms, Wendy van Eldijk
More than checking documents
The activities of the Local Feasibility Service Desk are carried out by the Human Research Compliance team. The Service Desk supports the internal approval process for research subject to the Dutch Medical Research Involving Human Subjects Act.
For Wendy van Eldijk, the award is also recognition of the supporting processes behind clinical research.
“Although the award is very rightly presented to Marjan and Linda, I find it special that the work behind the start-up of these studies is also being recognized,” she says. “Our aim is not simply to check whether a dossier is complete. We try to work together with researchers and research coordinators to solve questions quickly and help them build a complete, high-quality research file.”
Rather than relying solely on written comments in ResearchLiNC, the team actively contacts researchers when questions or missing information arise. According to Van Eldijk, this often prevents unnecessary back-and-forth communication and helps complex dossiers move forward more quickly.
“It is rewarding to see that this collaborative way of working is indirectly reflected in the award.”
Faster research, faster answers
The Ben Willem Mol Award is named after Ben Willem Mol, professor of obstetrics and gynecology and a strong advocate of evidence-based care and clinical evaluation research. The award emphasizes not only strong research ideas, but also the practical ability to set up studies efficiently and recruit enough patients to answer relevant clinical questions.
Appropriate care evaluation studies examines whether existing or new forms of care genuinely add value for patients. Its findings can contribute to appropriate care by helping identify treatments that are effective and useful, while reducing care that offers little benefit.
Daniëlla Borghuis, manager Clinical Research Support at the Research Institute, sees the recognition as particularly relevant at a time when accelerating clinical research is a national priority.
“This shows that Radboudumc can be an attractive partner for setting up and carrying out clinical studies,” she says. “Fast study start-up depends on good collaboration between researchers, research professionals, and support services. Local feasibility is an important part of that process.”
The award also reflects a broader ambition of the national 'Zorgevaluatie & Gepast Gebruik' program: shortening the time needed to conduct appropriate care evaluation studies so that new knowledge can reach patients and healthcare professionals sooner.





